Antimicrobial susceptibility of Clostridioides difficile to omadacycline and comparator antimicrobials.
Andrew M SkinnerLaurica A PetrellaAdam CheknisStuart JohnsonPublished in: The Journal of antimicrobial chemotherapy (2023)
Among 200 contemporary C. difficile isolates, there were no notable elevations in the in vitro omadacycline MIC, indicating a high level of activity towards C. difficile in comparison with commonly used antimicrobials for CABP and ABSSSI.
Keyphrases